Journal article icon

Journal article

[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].

Abstract:

OBJECTIVE: To compare the efficacy of the lipido-sterolic extract of Serenoa repens, Permixon, to that of the a-blocker, tamsulosin, in the treatment of severe low urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH). METHODS: In a 12-month, double-blind, randomized study that showed equivalent efficacy of Permixon 320 mg/day and tamsulosin 0.4 mg/day ("PERMAL study"), 685 BPH patients with IPSS > 10 had been analyzed for efficacy. Of these, the 124 patients with severe LUT...

Expand abstract
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences, Biomedical Research Centre
Role:
Author
Expand authors...
Journal:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
Volume:
14
Issue:
3
Pages:
326-331
Publication date:
2004-06-05
ISSN:
1166-7087
URN:
uuid:7b59aa46-123b-48ee-ae33-413408c20c22
Source identifiers:
120716
Local pid:
pubs:120716

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP